Page last updated: 2024-09-04

ivabradine and Abnormality, Heart

ivabradine has been researched along with Abnormality, Heart in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's4 (80.00)2.80

Authors

AuthorsStudies
Joshi, S; Kumar, G; Kumar, V; Ramamurthy, R; Sharma, V; Tiwari, N1
Chokhandre, M; Dharod, D; Joshi, S; Khan, N; Mandrekar, A; Salvi, P1
Ames, WA; Machovec, KA1
Imamura, T1
Jæger, KH; Tveito, A; Wall, S1

Reviews

1 review(s) available for ivabradine and Abnormality, Heart

ArticleYear
Use of Ivabradine in the Treatment of Tachyarrhythmias After Surgery for Congenital Heart Diseases.
    Journal of cardiothoracic and vascular anesthesia, 2020, Volume: 34, Issue:9

    Topics: Benzazepines; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Ivabradine; Tachycardia

2020

Other Studies

4 other study(ies) available for ivabradine and Abnormality, Heart

ArticleYear
Ivabradine as an Adjunct for Refractory Junctional Ectopic Tachycardia Following Pediatric Cardiac Surgery: A Preliminary Study.
    World journal for pediatric & congenital heart surgery, 2019, Volume: 10, Issue:6

    Topics: Cardiac Surgical Procedures; Cardiovascular Agents; Electrocardiography; Female; Heart Defects, Congenital; Heart Rate; Humans; Infant; Ivabradine; Male; Postoperative Complications; Retrospective Studies; Tachycardia, Ectopic Junctional; Treatment Outcome

2019
Big Syringe, Little Syringe.
    Journal of cardiothoracic and vascular anesthesia, 2020, Volume: 34, Issue:9

    Topics: Heart Defects, Congenital; Humans; Ivabradine; Syringes; Tachycardia

2020
What Is the Optimal Heart Rate Control for Atrial Tachyarrhythmia Following Cardiac Surgery?
    Journal of cardiothoracic and vascular anesthesia, 2021, Volume: 35, Issue:1

    Topics: Cardiac Surgical Procedures; Heart Defects, Congenital; Heart Rate; Humans; Ivabradine; Tachycardia

2021
Computational prediction of drug response in short QT syndrome type 1 based on measurements of compound effect in stem cell-derived cardiomyocytes.
    PLoS computational biology, 2021, Volume: 17, Issue:2

    Topics: Action Potentials; Adult; Ajmaline; Algorithms; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cell Line; Computational Biology; Drug Evaluation, Preclinical; Electrocardiography; ERG1 Potassium Channel; Heart Conduction System; Heart Defects, Congenital; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ivabradine; Mexiletine; Models, Cardiovascular; Mutation; Myocytes, Cardiac; Quinidine; Translational Research, Biomedical

2021